Project Title: |
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Obinutuzumab in Patients With ISN/RPS 2003 Class III or IV Lupus Nephritis |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Obinutuzumab in Patients With ISN/RPS 2003 Class III or IV Lupus Nephritis. |
Lead principal investigator(s): |
Dario Roccatello, Turin |
Co-investigator(s): |
Daniela Rossi, Turin Carla Naretto, Turin Mirella Apla, Turin |
Project Period: |
01/2016 - 01/2050 |
Sponsors: |
Industry |
EudraCT Nr.: |
2015-002022-39 |